Piperlongumine, 60 Capsules (Gerontis)

Piperlongumine — 60 Capsules (1 Bottle)

Piperlongumine, a highly potent natural alkaloid extracted from the long pepper (Piper longum). This standardized volume is optimized to provide a consistent supply for continuous evaluation or multi-cycle research within advanced oncology and cellular longevity frameworks.

General Pharmaceutical & Chemical Information

• Active Ingredient: Piperlongumine (Piplartine)
• Dosage: 20 mg of Piperlongumine per capsule
• Package Size: 1 Bottle (60 capsules)
• CAS Number: 20069-09-4
• Molecular Formula: C17H19NO5
• Form: Crystalline alkaloid enclosed in capsules
• Application: For Research Applications Only.

Primary Therapeutic Focus: Oncology Prevention and Management

The primary and most significant application of Piperlongumine lies in its profound potential for cancer prevention and therapeutic intervention in oncology. Decades of biomedical research have identified this alkaloid as a powerful, selective anti-tumor agent.

• Selective Cytotoxicity Against Cancer Cells: Piperlongumine possesses a unique ability to identify and destroy various malignant cells while completely sparing normal, healthy tissues.
• ROS-Induced Apoptosis: The compound targets the altered metabolic state of cancer cells by selectively elevating Reactive Oxygen Species (ROS) within them. This sudden increase in oxidative stress breaches the defense mechanisms of tumor cells, directly inducing apoptosis (programmed cell death).
• Inhibition of Tumor Migration and Metastasis: Studies indicate that Piperlongumine interferes with critical signaling pathways (such as PI3K/Akt/mTOR and NF-κB) responsible for tumor survival, proliferation, and angiogenesis, thereby helping to suppress the spread and migration of malignant cells.

Anti-Aging & Longevity Properties (Geroprotection & Senolysis)

In addition to its oncology-focused applications, Piperlongumine stands out as a premier natural senolytic and senomorphic agent within longevity strategies.

• Targeted "Zombie" Cell Clearance: It selectively induces apoptosis in senescent cells that accumulate with age, lowering the biological burden of damaged cellular material.
• Suppression of the SASP: By clearing senescent cells, Piperlongumine mitigates the Senescence-Associated Secretory Phenotype—the toxic cocktail of pro-inflammatory cytokines that drives systemic chronic inflammation (inflammaging) and creates a microenvironment favorable to both aging and tumor development.
• Protection Against Macromolecular Damage: It aids in cellular homeostasis by protecting proteins and cellular structures from cross-linking, helping to maintain overall tissue resilience.

Administration & Strict Disclaimer

In advanced research frameworks, senolytic and oncological compounds like Piperlongumine are typically integrated into intermittent "hit-and-run" dosing schedules rather than continuous daily use, allowing for periodic clearing of damaged cells without creating metabolic strain.

Strict Regulatory Disclaimer: This product is intended solely for laboratory research, in vitro evaluation, and analytical purposes. We do not provide medical advice, recommend specific protocols, or guarantee any therapeutic results. Nothing stated herein should be construed as a medical recommendation or a guarantee of efficacy in treating, curing, or preventing any disease, including cancer. Any practical application of this compound must be strictly validated by independent research and overseen by a qualified professional.